Literature DB >> 10601514

Choosing the best initial therapy for HIV-1 infection.

N Clumeck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601514     DOI: 10.1056/NEJM199912163412510

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy.

Authors:  Eugenia Quiros-Roldan; Monica Airoldi; Francesca Moretti; Caterina Fausti; Angelo Pan; Salvatore Casari; Carlo Torti; Francesco Castelli; Giampiero Carosi
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 2.  Delavirdine: a review of its use in HIV infection.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.

Authors:  S Maddocks; D Dwyer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.

Authors:  D P Figgitt; G L Plosker
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

Review 5.  Efavirenz: a pharmacoeconomic review of its use in HIV infection.

Authors:  G L Plosker; C M Perry; K L Goa
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 6.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.